Metric Finance
LearnFAQ
LearnFAQ

Learn / OBX

NASDAQ: OBX

Obsidian Therapeutics (OBX) stock, explained like you're 5

Obsidian Therapeutics trades on the Nasdaq under the ticker OBX. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 803 million dollars.

Ticker
OBX
Exchange
Nasdaq
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Small cap, about 803 million dollars

Is Obsidian Therapeutics a small, medium or large cap company?

No. Obsidian Therapeutics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 803 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Obsidian Therapeutics makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves OBX stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Obsidian Therapeutics (OBX) Stock Price, News & Analysis (Stock Titan)
  • symbol__ Stock Quote Price and Forecast (CNN)
  • Obsidian Therapeutics (OBX) Stock Dropped, So What Is Behind The Attention Now? (Yahoo Finance)
  • Norway stocks higher at close of trade; Oslo OBX up 0.96% (Investing.com)
  • Obsidian Therapeutics (Nasdaq:OBX) Stock Analysis (Simply Wall Street)

Follow OBX in your daily brief

Each trading day at 5 PM ET we post what happened to Obsidian Therapeutics and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow OBX

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Obsidian Therapeutics stock

What does Obsidian Therapeutics do?

Obsidian Therapeutics trades on the Nasdaq under the ticker OBX. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 803 million dollars.

What is the ticker symbol for Obsidian Therapeutics?

Obsidian Therapeutics trades under the ticker OBX on the Nasdaq.

What is Obsidian Therapeutics's market cap?

Obsidian Therapeutics is a small cap stock with a market cap of about 803 million dollars.

How does Obsidian Therapeutics make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves OBX stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow OBX stock every day?

Add OBX to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow OBX daily

A free brief on Obsidian Therapeutics and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare OBX: OBX vs NVS, OBX vs AZN, OBX vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed